These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15013934)

  • 1. A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine.
    Pascual J
    Expert Opin Pharmacother; 2004 Mar; 5(3):669-77. PubMed ID: 15013934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
    Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rizatriptan: a review of its efficacy in the management of migraine.
    Dooley M; Faulds D
    Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L;
    Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
    Solomon S; Frishberg B; Hu XH; Markson L; Berger M
    Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
    MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rizatriptan. Convenience and consistency.
    Evans RW
    Postgrad Med; 2000 Sep; 108(3 Suppl):10-5. PubMed ID: 19667525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP; Gawel M
    Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rizatriptan (Maxalt), a new entity of triptan for migraine: pharmacology and therapeutic relevance].
    Ikemoto F; Toru T; Aijima H; Natsumeda Y
    Nihon Yakurigaku Zasshi; 2004 Apr; 123(4):295-302. PubMed ID: 15056946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
    Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rizatriptan: experience after 15 years of clinical use].
    Ramón-Carbajo C; Alvarez-Escudero R; Pascual J
    Rev Neurol; 2013 Dec; 57(12):549-55. PubMed ID: 24288104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
    Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK
    Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis.
    Göbel H
    Expert Rev Neurother; 2010 Apr; 10(4):499-506. PubMed ID: 20367203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rizatriptan: an update of its use in the management of migraine.
    Wellington K; Plosker GL
    Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials.
    Tfelt-Hansen P; Ryan RE
    Neurology; 2000; 55(9 Suppl 2):S19-24. PubMed ID: 11089515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rizatriptan: pharmacological differences from sumatriptan and clinical results.
    Lines CR; McCarroll KA; Visser WH
    Curr Med Res Opin; 2001; 17 Suppl 1():s54-8. PubMed ID: 12463279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
    Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
    Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.